ERK2 Antibody from FORTIS LIFE SCIENCES
Search, find, compare suppliers for anti-ERK2 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ERK2 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, (presumed: rat, bovine) |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 10 µl |
| Concentration | 1000 µg/ml |
| Applications | WB, IHC |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Rabbit anti-ERK2 Antibody, Affinity Purified. Extracellular signal-regulated kinase 2 (ERK2/p42) is also known as mitogen-activated protein kinase 1 (MAPK1). ERK2 is part of a signal transduction pathway that begins with the small GTPase Ras and continues through a cascade of protein kinases that include Raf and MEK. Activation of this signaling pathway influences many cellular processes such as proliferation, differentiation and survival. ERK2 is very similar in sequence to ERK1/p44 and the activities of both ERK1 and ERK2 are usually considered together as total ERK activity. More recent evidence has shown that ERK1 and ERK2 are not functionally redundant and may have very different and specific roles. |
| Immunogen | Epitope: between 310 and 360 |
| Other Names | PRKM1; p38; p40; p41; p41mapk; P42MAPK; ERK2; PRKM2; protein tyrosine kinase ERK2; mitogen-activated protein kinase 2; p42-MAPK; ERT1; ERK; ERK-2; extracellular signal-regulated kinase 2; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42; MAPK 1; MAPK 2; MAPK2; mitogen-activated protein kinase 1 |
| Gene, Accession # | Gene ID: 5594, Accession: NP_002736.3, UniProt: P28482 |
| Catalog # | A302-061A-T |
| Price | $121 |
| Order / More Info | ERK2 Antibody from FORTIS LIFE SCIENCES |
| Product Specific References | n/a |
FORTIS LIFE SCIENCES
FORTIS LIFE SCIENCES
1440 Main Street, Suite 300
Waltham MA 02451
P: 800.338.9579
info@fortislife.com
https://www.fortislife.com
Profile of FORTIS LIFE SCIENCES
Return to Antibodies